Executive Director, Life Sciences, IHS Markit
Paris & London
Gustav Ando, executive director for the Economics and Country Risk Life Sciences practice at IHS Markit, has overall responsibility for the teams that provide pricing and reimbursement, healthcare microsimulation and competitive intelligence solutions to the global pharmaceutical industry. Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances. He heads the research teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.